Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
C4 Therapeutics (CCCC) Q3 2023 Earnings
CCCC
1
Nov
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.76
-0.69
-0.62
-0.55
Details
Expected EPS
-0.66
Actual EPS
-0.55
Surprise EPS
0.11
Surprise Percent
+16.67%
Description
C4 Therapeutics (CCCC) has reported earnings of -0.55 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login